“evolocumab” Archives

in
Entry Author Date Location
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B 11/25/19 New York
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.) 08/26/19 National
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms 05/20/19 New York
Matching Amgen, Regeneron to Cut List Price of Heart Drug by 60% 02/11/19 New York
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Amgen Slashes Cholesterol Drug Price 60% to Match Rival Regeneron 10/24/18 National
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
Express Scripts Picks Regeneron Over Amgen, Cuts Heart Drug Price 05/01/18 New York
Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More 04/06/18 National
Regeneron to Slash Price of Cholesterol Drug After Showing It Saved Lives 03/10/18 New York
Esperion Touts Low Cholesterol Drug Price, But Not All Data are Ready 03/07/18 Detroit Ann Arbor
Notes From the JPM ’18 Vortex: Gene Therapy’s Reckoning and Lonely Cabs 01/11/18 National
With Good Data From Rival Migraine Drugs, Doctors Foresee Price Headaches 11/29/17 San Francisco
Medicines Co. Sells Infectious Disease Drugs, Focusing on PCSK9 11/29/17 New York
Novartis: CAR-T Results In One Month, Or No Charge. Why One Month? 08/31/17 National
Will Merck Seek FDA Filing For Heart Drug After Lackluster Results? 08/29/17 New York
Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand 08/25/17 National
70% Repatha Cut? Amgen Counters With Own Study To Justify Price 08/23/17 National
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Amgen’s Heart Data Don’t Impress Drug-Price Evaluation Group 06/13/17 San Francisco
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC 03/24/17 National
With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work 03/17/17 San Francisco
Bio Roundup: Travel Ban Block, Gilead Shock, Dean Kamen Talk & More 02/10/17 National
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
Regeneron: It’s Still Wait Until 2017 For Big Heart Drug Study 11/17/16 New York
With New Data, Medicines Co. Takes Long-Lasting Heart Drug to Phase 3 11/15/16 New York
Arrowhead Teams Up with Amgen to Develop Cardiovascular Drugs 09/29/16 Wisconsin
In Cholesterol Drug Price Fight, Real Message Is “Wait Til Next Year” 08/18/16 National
Intercept’s Liver Drug Wins FDA Approval To Treat Rare Disease 05/28/16 New York
Page 1 of 2 next page »